Dimension Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Dimension Therapeutics, Inc. reported Increase (Decrease) in Deferred Revenue of -$1.77 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-11-06
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$1.70M.
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$1.27M.
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $1.20M, a 11.45% increase year-over-year.
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was -$2.25M.
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$3.18M.
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$2.14M, a 109.44% decline from fiscal 2014.
- Dimension Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2014 was $22.64M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$2.97M derived: sum of 2 quarters · filed 2017-11-06 | -$1.77M 10-Q · filed 2017-11-06 | -$4.02M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$74.00K 10-Q · filed 2017-08-08 | -$2.32M derived: sum of 3 quarters · filed 2017-08-08 | -$3.28M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | $1.20M 10-Q · filed 2017-05-10 | -$1.05M derived: sum of 2 quarters · filed 2017-05-10 | -$2.00M derived: sum of 3 quarters · filed 2017-11-06 | -$3.06M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$3.20M derived: sum of 2 quarters · filed 2017-11-06 | -$4.25M derived: sum of 3 quarters · filed 2017-11-06 | -$3.18M 10-K · filed 2017-03-09 |
| 2016-09-30 | -$955.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$2.01M derived: sum of 2 quarters · filed 2017-11-06 | -$932.00K 10-Q · filed 2017-11-06 | -$3.14M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $23.00K 10-Q · filed 2017-08-08 | -$2.19M derived: sum of 3 quarters · filed 2017-08-08 | -$2.15M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-10 | -$1.14M derived: sum of 2 quarters · filed 2017-05-10 | -$1.10M derived: sum of 3 quarters · filed 2017-05-10 | -$1.27M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$2.18M derived: sum of 2 quarters · filed 2017-03-09 | -$2.34M derived: sum of 3 quarters · filed 2017-03-09 | -$2.14M 10-K · filed 2017-03-09 |
| 2015-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$131.00K derived: sum of 2 quarters · filed 2016-11-10 | $72.00K 10-Q · filed 2016-11-10 | $2.77M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | -$162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $41.00K 10-Q · filed 2016-08-11 | $2.73M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2015-03-31 | $203.00K 10-Q · filed 2016-05-12 | $2.90M derived: sum of 2 quarters · filed 2017-03-09 | ||
| 2014-12-31 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $22.64M 10-K · filed 2017-03-09 | ||
| 2014-09-30 | $19.95M 10-Q · filed 2015-12-04 |